Mangoceuticals Enters Debt Conversion Agreement with Mill End Capital Ltd
Dallas, Texas – January 15, 2025 – Mangoceuticals, Inc. (NASDAQ:MGRX) announced today the signing of a Debt Conversion Agreement with Mill End Capital Ltd. The agreement revolves around a previous outstanding Promissory Note dating back to October 18, 2024, currently amounting to $150,000. This note, originally issued to Cohen Enterprises, Inc., was acquired by Mill […]
More Stories
Supreme Court to Hear Dispute Over Access to DOGE Records
By Matthew Vadum The Supreme Court on Oct. 13 agreed to decide whether a federal judge improperly ordered broad discovery...
Is Imperfect Women Season 2 Renewed?
Apple TV just dropped the most-awaited news for psychological thriller fans. Imperfect Women season 2 is happening. If you watched...
What Makes Live Dealer Casino Games Feel Like the Real Table?
There is a noticeable difference between watching an animated roulette wheel and seeing a real ball circle a physical wheel....
How to Match Native Display Ads to Your Content and Campaign Goals
A native campaign can struggle when the ad attracts one kind of interest but the destination asks for something different....
491 Fugitives Hiding in Public Housing Arrested in Nationwide Sweep
By Naveen Athrappully A multi-month law enforcement operation has led to the arrests of 491 criminal fugitives living in government-assisted...
Trump Doubles Down on $5,000 Payments Tied to Midterm Results
By Jack Phillips President Donald Trump on Monday released a new advertisement that doubled down on his promise to send...